The involvement of STING in pulmonary inflammation and vasculopathy in COVID-19 prompted the comparison with SAVI disease, suggesting that gene polymorphisms in the STING pathway could also be associated with COVID-19 (Berthelot and Lioté, 2020). The gene discussed is STING1; the disease is COVID-19.